Weather Alert(1)!
"Winter Weather Advisory" ...Winter Weather Advisory remains in effect from 10 am this morning to 7 am EST Monday... * locations...New York City...Long Island...northeast New Jersey...the lower Hudson Valley and Fairfield County. * Hazard types...snow...with freezing rain across New York City... Long Island...most of northeast New Jersey...and coastal portions of the lower Hudson Valley and Fairfield County. * Accumulations...snow accumulation of 3 to 5 inches...along with around a trace of ice. * Visibilities...one quarter to one half mile at times. * Timing...snow develops late this morning over western portions of the tri-state...then expands over the remainder of the advisory area this afternoon. The snow will mix with or change to freezing rain across New York City... Long Island...most of northeast New Jersey...and coastal portions of the lower Hudson Valley and Fairfield County Sunday evening. The precipitation will taper off from west to east after midnight tonight. * Impacts...snow covered surfaces...coated with ice in areas... will make traveling difficult at times. Precautionary/preparedness actions... A Winter Weather Advisory means that periods of snow...sleet...or freezing rain will cause travel difficulties. Be prepared for slippery roads and limited visibilities...and use caution while driving. -- Sunday Mar.01 15,03:36 AM Weather  |  LIRR  |  Traffic  |  Traffic Cams |  Weather News

 

ADRC Distributes Its First Research Grant

Press Releases

The grant will assist a study on how the removal of Namenda from the marketplace and the use of its substitute will impact the patients ...

Mineola, NY - June 27, 2014 - On June 26, Mary Ann Malack-Ragona, Executive Director/CEO, Alzheimer’s Disease Resource Center, Inc., presented a check in the amount of $3,000 to Dr. Irving H. Gomolin, Chief, Division of Geriatric Medicine, Winthrop-University Hospital, in Mineola. The grant will assist Dr. Gomolin’s study on how the removal of Namenda from the marketplace and the use of its substitute — an extended release formulation — will impact the blood levels of patients with Alzheimer’s Disease or dementia.
 
Namenda — also known as Memantine — is an oral medication used to treat moderate to severe dementia related to Alzheimer’s Disease. While it does not cure AD, it may improve memory, awareness and the ability to perform daily functions. Namenda works by blocking the action of glutamate, a natural substance in the brain that is believed to be linked to symptoms of AD.
 
The standard tablet formulation of the drug is being removed from the marketplace in August 2014 without any available generic versions in the U.S. because patent rights to the drug do not expire until 2015. Instead, Alzheimer’s patients can be switched to an extended release formulation of Memantine.
 
The grant came from part of an anonymous donation that ADRC recently received. This was the first research study the organization has funded.
 
Alzheimer’s Disease Resource Center, Inc. — which is headquartered in Bay Shore and has a satellite office in Southampton — is the only local Alzheimer’s Disease advocacy and educational facility whose mission is to provide hands-on support and services to families on Long Island and the New York metropolitan area. ADRC works with family members, health care professionals and researchers to ensure quality health care and support to those impacted by Alzheimer’s Disease through care and consultation, information and referral, training, support groups, and caregiver safety products.
 
Pictured (left to right): Mary Ann Malack-Ragona, Executive Director/CEO, Alzheimer’s Disease Resource Center, Inc.; Dr. Irving H. Gomolin, Chief, Division of Geriatric Medicine, Winthrop-University Hospital; and Linda Martinez, Licensed Clinical Social Worker, Department of Geriatrics, Winthrop-University Hospital.
comments powered by Disqus

Join Our Weekly Newsletter

Sign up for a free weekly newsletter covering things to do, hottest local headlines, and everything Long Island! Read more here or enter your email to signup.

   
     Newsletter Archive
Advertisement
Advertise With Us
 
Open Feedback Dialog